| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences, Inc. (NERV) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. NERV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.25M | $13.23M | - | |
| Pres | 1.50M | $8.82M | - | |
| CFO | 500.0K | $2.94M | - | |
| Dir | 364.5K | $2.14M | - | |
| Dir | 50.0K | $294.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2018 | Doyle William F53 | Director | Buy | 2,200 | $10.50 | $23,100.00 | +12.2% | |
| Sep 11, 2018 | Doyle William F53 | Director | Buy | 8,011 | $9.80 | $78,506.92 | +200.3% | |
| Aug 23, 2018 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 25,000 | $10.00 | $250,000.00 | -63.8% | |
| Dec 14, 2017 | Luthringer Remy | CEO | Sale+OE | 2,194 | $5.85 | $12,834.90 | -11.7% | |
| Dec 14, 2017 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 2,906 | $5.80 | $16,854.80 | -17.0% | |
| Dec 14, 2017 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 1,661 | $5.80 | $9,633.80 | -16.6% | |
| Dec 14, 2017 | Race Geoff | EVP, CFO &Cbo | Sale+OE | 5,829 | $5.79 | $33,749.91 | -2.9% | |
| Jun 1, 2017 | Levine Mark S.66 | SVP,General Counsel &Sec. | Sale+OE | 17,500 | $11.00 | $192,500.00 | -100% | |
| Jun 1, 2017 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 21,631 | $10.48 | $226,691.00 | -51.5% | |
| Mar 20, 2017 | Beer Marc D | Director | Buy | 50,000 | $8.12 | $405,750.00 | +200.0% |